Tirzepatide Cost 2026: Brand-Name and Compounded Pricing Explained
Quick answer: How much does tirzepatide cost?
Tirzepatide is available through two separate pathways in 2026: the FDA-approved brand products and the compounded route. Brand-name Mounjaro retails at ~$1,049/month and Zepbound at ~$1,177/month without insurance. With insurance, copays range $25-$300/month depending on plan. On the compounded pathway, Trimi Health is $125/month on the annual plan ($1,500/yr all-inclusive, medication, US-licensed clinician, free shipping), and compounded preparations are not FDA-approved as drugs. The compounded version is dispensed by 503A community sterile compounding pharmacies (VialsRx, Texas State Board pharmacy license #35264, and GreenwichRx) under USP <797> sterile compounding standards. The SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine, 2022) studied FDA-approved tirzepatide and demonstrated 20.9% mean body-weight reduction at the 15 mg maintenance dose over 72 weeks.
Compounded Tirzepatide Cost Snapshot
Monthly
Varies
Depends on provider and bundled support
Longer-term plans
Varies
Verify savings terms directly
Dose increases
No change
Trimi charges the same at any dose
Always verify current pricing directly with any provider before enrolling.
Understanding Tirzepatide Costs in 2025
Tirzepatide can be effective for many patients, but cost comparisons should be treated carefully because brand cash-pay pricing, compounded program pricing, and support models can change over time.
Compounded tirzepatide discussions are strongest when they explain what affects cost, what is bundled into the program, and how legitimacy and pharmacy route fit into the decision. This guide focuses on those comparison questions rather than promising a fixed savings figure.
Brand Name vs Compounded: How the Pathways Differ
Mounjaro (Brand)
- FDA Status
- FDA-approved for type 2 diabetes
- How It's Dispensed
- Retail pharmacy, prefilled pen
- Quality Oversight
- Eli Lilly cGMP manufacturing, FDA inspected
Zepbound (Brand)
- FDA Status
- FDA-approved for chronic weight management
- How It's Dispensed
- Retail pharmacy, prefilled pen
- Quality Oversight
- Eli Lilly cGMP manufacturing, FDA inspected
Compounded Tirzepatide
- FDA Status
- Not FDA-approved as a drug
- How It's Dispensed
- Telehealth, shipped from a 503A pharmacy
- Quality Oversight
- State pharmacy board licensure, USP <797> standards
| Option | FDA Status | How It's Dispensed | Quality Oversight |
|---|---|---|---|
| Mounjaro (Brand) | FDA-approved for type 2 diabetes | Retail pharmacy, prefilled pen | Eli Lilly cGMP manufacturing, FDA inspected |
| Zepbound (Brand) | FDA-approved for chronic weight management | Retail pharmacy, prefilled pen | Eli Lilly cGMP manufacturing, FDA inspected |
| Compounded Tirzepatide | Not FDA-approved as a drug | Telehealth, shipped from a 503A pharmacy | State pharmacy board licensure, USP <797> standards |
Compounded tirzepatide from $125/mo, prescribed and dispensed by licensed US pharmacies
Trimi's compounded tirzepatide is $125/month on the annual plan ($1,500/yr, all-inclusive: medication, US-licensed clinician via the Arora Health 50-state network, and free shipping). It is dispensed by licensed 503A community sterile compounding pharmacies (VialsRx, Texas State Board #35264, and GreenwichRx). Compounded preparations are not themselves FDA-approved as drugs; individual results vary, and a licensed clinician decides whether treatment is appropriate.
What's Included in the Price?
Reputable compounded tirzepatide providers typically bundle the following into one monthly price:
Trimi Health Pricing
Annual Plan
$125
per month ($1,500/year)
All-inclusive, same price at any dose
- Medication, clinician, and shipping included
- Same price from 2.5mg to 15mg
- No hidden fees, cancel anytime
What to Know First
503A
community sterile compounding route
VialsRx (TX #35264) · GreenwichRx
- Prepared per individual prescription
- Not FDA-approved as a drug
- Prescribed only after clinician evaluation
A licensed clinician decides whether treatment is appropriate.
Factors That Affect Compounded Tirzepatide Cost
1. Pharmacy Type (503A vs 503B)
503B facilities (outsourcing facilities) often have slightly higher costs due to increased FDA oversight, but this can mean better quality control.
Typical range: 503A: $125-$349 | 503B: $350-$450 (Trimi is a 503A route at $125/mo annual)
2. Included Services
Providers offering comprehensive care (consultations, support, supplies) may charge more but provide better value.
3. Supply Chain & Raw Materials
Prices fluctuate based on availability of pharmaceutical-grade tirzepatide from FDA-registered suppliers.
4. Subscription Length
Longer commitments (3, 6, or 12 months) typically offer 15-25% savings vs month-to-month.
Is Compounded Tirzepatide Worth the Cost?
Expected Results & ROI
Average Weight Loss
20-25%
of body weight in 12 months
Monthly Cost Per Pound Lost
~$8-12
based on avg 25-30 lbs lost
When you consider the health benefits (reduced diabetes risk, improved cardiovascular health, better quality of life), many patients find compounded tirzepatide to be an excellent investment in their long-term health.
In the SURMOUNT-1 trial, participants taking tirzepatide had a mean body-weight reduction of 20.9% at the 15 mg maintenance dose over 72 weeks.Jastreboff AM et al., Tirzepatide Once Weekly for the Treatment of Obesity, New England Journal of Medicine 2022;387:205–216. Clinical-trial average; individual results vary.
Hidden Costs to Watch Out For
When comparing prices, beware of providers that advertise low costs but add hidden fees:
- •Consultation fees: Some charge $99-$299 per consultation
- •Shipping costs: $15-$30 per shipment
- •Membership fees: Monthly platform fees
- •Supplies not included: Syringes sold separately
- •Price increases by dose: Higher doses cost more
💡 Trimi includes everything - no hidden fees, same price at any dose
Pricing FAQs
Does insurance cover compounded tirzepatide?
Generally no. Insurance typically only covers FDA-approved brand medications, so compounded tirzepatide is billed as a cash-pay program rather than through a plan.
Can I use my HSA/FSA?
Yes! Compounded tirzepatide prescribed by a licensed provider is typically HSA/FSA eligible.
Do prices go up when my dose increases?
Not with Trimi. We charge the same price regardless of dose, from 2.5mg to 15mg.
Are there cheaper options online?
Be cautious with anything sold without a prescription or as a "research chemical" from unverified or overseas sources - that is illegal and unsafe regardless of price. Legitimate compounded tirzepatide is dispensed by licensed 503A pharmacies only after a clinician's prescription; quality-verified telehealth providers typically range about $125-$349/month (Trimi is $125/month on the annual plan).
Related Articles
Get Started with Compounded Tirzepatide
$125/month on the annual plan, all-inclusive
No hidden fees • Free shipping • Same price at any dose
Related Reading
- Cheapest Legal GLP-1 Online (2026, 50 States), Definitive cornerstone covering Hims, Ro, Found, Mochi, Henry Meds, LillyDirect with 503A pharmacy compliance citations
- Tirzepatide Side Effects Guide
- Tirzepatide Dosage Guide
- Tirzepatide Weight Loss Results
- Tirzepatide vs Semaglutide 2026
- Tirzepatide Treatment Page
- Cheapest GLP-1 Options 2026
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Tirzepatide is a prescription GLP-1/GIP receptor agonist. Common and serious risks include nausea, vomiting, diarrhea, and abdominal pain, and less commonly pancreatitis (inflammation of the pancreas), gallbladder disease, acute kidney injury (often from dehydration), low blood sugar (especially when combined with insulin or sulfonylureas), and severe allergic reactions. Tirzepatide carries a boxed warning: in rodent studies it caused thyroid C-cell tumors, and it is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Compounded tirzepatide is prepared by licensed compounding pharmacies and is not FDA-approved as a drug (the active ingredient, tirzepatide, is FDA-approved in the brand products Mounjaro and Zepbound). Individual results vary. Always consult a licensed clinician before starting, changing, or stopping any medication or treatment program.